Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor Hematopoietic Stem Cell Transplant.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Abatacept (Primary) ; Ciclosporin; Methotrexate
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 18 Nov 2009 New trial record